| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000010202 |
| Receipt No. | R000011943 |
| Official scientific title of the study | Role of Serum Procalcitonin in Diagnosis and Management of Biliary Tract Infection |
| Date of disclosure of the study information | 2013/03/11 |
| Last modified on | 2017/09/12 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Role of Serum Procalcitonin in Diagnosis and Management of Biliary Tract Infection | |
| Title of the study (Brief title) | Role of Serum Procalcitonin in Diagnosis and Management of Biliary Tract Infection | |
| Region |
|
|
| Condition | |||
| Condition | Biliary tract infection | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Study 1. To evaluate the efficacy of procalcitonin in the diagnosis and severity assessment of biliary tract infection.
Study 2. To evaluate the role of procalcitonin as a predictor of efficacy of treatment for biliary tract infection. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Study 1. To determine the cut-off value of serum procalcitonin in the diagnosis and severity assessment of biliary tract infection.
Study 2. To examine the correlation between time to defervescence and serum procalcitonin value in patients with biliary tract infection. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Study 1. Patients with acute cholangitis, acute cholecystitis, or liver abscess, who started antibiotic therapy at the time of admission.
Study 2. Patients with acute cholangitis, acute cholecystitis, or liver abscess, who started antibiotic therapy at the time of admission and who received endoscopic or percutaneous drainage. Patients with written informed consent. |
|||
| Key exclusion criteria | 1) Patients with other active concomitant infections.
2) Patients considered ineligible for this study. |
|||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Hirofumi Kogure |
| Organization | Faculty of Medicine, The University of Tokyo |
| Division name | Department of Gastroenterology |
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo |
| TEL | 03-3815-5411 |
| kogureh-tky@umin.ac.jp | |
| Public contact | |
| Name of contact person | Hirofumi Kogure |
| Organization | Faculty of Medicine, The University of Tokyo |
| Division name | Department of Gastroenterology |
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo |
| TEL | 03-3815-5411 |
| Homepage URL | |
| kogureh-tky@umin.ac.jp | |
| Sponsor | |
| Institute | Faculty of Medicine, The University of Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | Study 1. Serum procalcitonin value at the time of admission.
Study 2. Sequential change of serum procalcitonin value before and after treatment. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000011943 |